ブラウザの設定でJava Scriptの使用を有効にしてご利用ください。
出典:Wikipedia
出典:『Wikipedia』 (2011/07/01 04:00 UTC 版)
Mifamurtide (trade name Mepact, marketed by Takeda) is a drug against osteosarcoma, a kind of bone cancer mainly affecting children and young adults, which is lethal in about a third of cases. The drug was approved in Europe in March 2009.
mifamurtide